Ashraf Khan to Female
This is a "connection" page, showing publications Ashraf Khan has written about Female.
Connection Strength
0.369
-
Sung K, Nawaz M, Park M, Chon J, Khan SA, Alotaibi K, Khan AA. Comprehensive Genomic Analysis of Uropathogenic E. coli: Virulence Factors, Antimicrobial Resistance, and Mobile Genetic Elements. Pathogens. 2024 Sep 13; 13(9).
Score: 0.049
-
Goodman S, Khan A. Florid Cystic Endosalpingiosis. Int J Surg Pathol. 2014 Jun; 22(4):336.
Score: 0.024
-
Khan A. Five top stories in breast pathology. Arch Pathol Lab Med. 2014 Jan; 138(1):14-5.
Score: 0.023
-
Yang X, Kandil D, Cosar EF, Khan A. Fibroepithelial tumors of the breast: pathologic and immunohistochemical features and molecular mechanisms. Arch Pathol Lab Med. 2014 Jan; 138(1):25-36.
Score: 0.023
-
Goodman S, O'Connor A, Kandil D, Khan A. The ever-changing role of sentinel lymph node biopsy in the management of breast cancer. Arch Pathol Lab Med. 2014 Jan; 138(1):57-64.
Score: 0.023
-
Moghaddam PA, Cornejo KM, Khan A. Metastatic carcinoma to the thyroid gland: a single institution 20-year experience and review of the literature. Endocr Pathol. 2013 Sep; 24(3):116-24.
Score: 0.023
-
Virk RK, Khan A. Pseudoangiomatous stromal hyperplasia: an overview. Arch Pathol Lab Med. 2010 Jul; 134(7):1070-4.
Score: 0.018
-
Walter O, Prasad M, Lu S, Quinlan RM, Edmiston KL, Khan A. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype. Hum Pathol. 2009 Nov; 40(11):1528-33.
Score: 0.017
-
Slosar M, Vohra P, Prasad M, Fischer A, Quinlan R, Khan A. Insulin-like growth factor mRNA binding protein 3 (IMP3) is differentially expressed in benign and malignant follicular patterned thyroid tumors. Endocr Pathol. 2009; 20(3):149-57.
Score: 0.017
-
Istvanic S, Fischer AH, Banner BF, Eaton DM, Larkin AC, Khan A. Cell blocks of breast FNAs frequently allow diagnosis of invasion or histological classification of proliferative changes. Diagn Cytopathol. 2007 May; 35(5):263-9.
Score: 0.015
-
Khan A, Vohra P, Quinlan RF. The role of sentinel lymph node biopsy in the management of breast cancer. Indian J Pathol Microbiol. 2007 Apr; 50(2):261-9.
Score: 0.015
-
Ciampa A, Xu B, Ayata G, Baiyee D, Wallace J, Wertheimer M, Edmiston K, Khan A. HER-2 status in breast cancer: correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system. Appl Immunohistochem Mol Morphol. 2006 Jun; 14(2):132-7.
Score: 0.014
-
Rezk S, Yousef M, Zamansky M, Khan A. Solitary fibrous tumor of the auditory canal. Arch Pathol Lab Med. 2004 Dec; 128(12):e169-71.
Score: 0.012
-
Mitrou A, Feng X, Khan A, Yaroslavsky AN. Feasibility of dual-contrast fluorescence imaging of pathological breast tissues. J Biophotonics. 2021 08; 14(8):e202100007.
Score: 0.010
-
Liao H, Khan A, Miron PM, Cornejo KM. Mammary Analogue Secretory Carcinoma of the Thyroid Mimicking Locally Advanced Papillary Thyroid Carcinoma: A Rare Case Report. Int J Surg Pathol. 2018 Aug; 26(5):459-463.
Score: 0.008
-
Galera P, Khan A, Kandil D. Diagnosis of Metaplastic Breast Carcinoma: Keratin OSCAR Versus Other Cytokeratins. Appl Immunohistochem Mol Morphol. 2016 10; 24(9):622-626.
Score: 0.007
-
Cornejo KM, Deng A, Wu H, Cosar EF, Khan A, St Cyr M, Tomaszewicz K, Dresser K, O'Donnell P, Hutchinson L. The utility of MYC and FLT4 in the diagnosis and treatment of postradiation atypical vascular lesion and angiosarcoma of the breast. Hum Pathol. 2015 Jun; 46(6):868-75.
Score: 0.006
-
Patel R, Khan A, Quinlan R, Yaroslavsky AN. Polarization-sensitive multimodal imaging for detecting breast cancer. Cancer Res. 2014 Sep 01; 74(17):4685-93.
Score: 0.006
-
Zhao L, Yang X, Khan A, Kandil D. Diagnostic role of immunohistochemistry in the evaluation of breast pathology specimens. Arch Pathol Lab Med. 2014 Jan; 138(1):16-24.
Score: 0.006
-
Leidy J, Khan A, Kandil D. Basal-like breast cancer: update on clinicopathologic, immunohistochemical, and molecular features. Arch Pathol Lab Med. 2014 Jan; 138(1):37-43.
Score: 0.006
-
Cornejo KM, Kandil D, Khan A, Cosar EF. Theranostic and molecular classification of breast cancer. Arch Pathol Lab Med. 2014 Jan; 138(1):44-56.
Score: 0.006
-
Patel R, Khan A, Kamionek M, Kandil D, Quinlan R, Yaroslavsky AN. Delineating breast ductal carcinoma using combined dye-enhanced wide-field polarization imaging and optical coherence tomography. J Biophotonics. 2013 Sep; 6(9):679-86.
Score: 0.005
-
Patel R, Khan A, Wirth D, Kamionek M, Kandil D, Quinlan R, Yaroslavsky AN. Multimodal optical imaging for detecting breast cancer. J Biomed Opt. 2012 Jun; 17(6):066008.
Score: 0.005
-
Ortiz-Pagan S, Cunto-Amesty G, Narayan S, Crawford S, Derrick C, Larkin A, Khan A, Quinlan R, Layeequr Rahman R. Effect of Paget's disease on survival in breast cancer: an exploratory study. Arch Surg. 2011 Nov; 146(11):1267-70.
Score: 0.005
-
Buttar A, Mittal K, Khan A, Bathini V. Effective role of hormonal therapy in metastatic primary neuroendocrine breast carcinoma. Clin Breast Cancer. 2011 Oct; 11(5):342-5.
Score: 0.005
-
Clark JL, Dresser K, Hsieh CC, Sabel M, Kleer CG, Khan A, Shaw LM. Membrane localization of insulin receptor substrate-2 (IRS-2) is associated with decreased overall survival in breast cancer. Breast Cancer Res Treat. 2011 Dec; 130(3):759-72.
Score: 0.005
-
Lee CW, Simin K, Liu Q, Plescia J, Guha M, Khan A, Hsieh CC, Altieri DC. A functional Notch-survivin gene signature in basal breast cancer. Breast Cancer Res. 2008; 10(6):R97.
Score: 0.004
-
Lu S, Simin K, Khan A, Mercurio AM. Analysis of integrin beta4 expression in human breast cancer: association with basal-like tumors and prognostic significance. Clin Cancer Res. 2008 Feb 15; 14(4):1050-8.
Score: 0.004
-
Schmidt M, Khan A, Schmidt AM, Heinze B, Hack E, Waltenberger J, Kreienberg R. A novel breast cancer cell line initially established from pleural effusion: evolution towards a more aggressive phenotype. Int J Oncol. 2007 Mar; 30(3):565-72.
Score: 0.004
-
Ciampa A, Fanger G, Khan A, Rock KL, Xu B. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas. Cancer. 2004 Dec 25; 102(6):368-72.
Score: 0.003